Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events cdfs pdfs comparing visual methods supporting responder thresholds clinical
… This class illustrates that you really have to apply your clinical knowledge and assess the information critically to …
… of market competition. Diversity and Health Equity in Clinical Trials Programming at ASCO emphasized the importance of diversity and health equity in clinical trials and observational studies. Ensuring diverse … of cancer treatment. At RTI-HS, we are committed to supporting these advances, bringing our extensive experience …
2023 AANEM Annual Meeting Share on: Wednesday, November 1 - Saturday, November 4, 2023 Conference website Research coauthored by RTI Health Solutions experts will be presented at the 2023 AANEM Annual Meeting. A comparative real-world study evaluating …
… additional economic value along with the studied clinical parameters can make your technology more attractive … Insight: When pitching to investors, integrating clinical efficacy data with strong nonclinical evidence (like …
… present all safety data and a thorough review of the clinical evidence. However, the value messages will focus on … are identified correctly, that the interpretation of the clinical data is both robust and impactful and that any local …
Stephanie Earnshaw Honored with NC State University Distinguished Alumnus Award Share on: December 8, 2022 Congratulations to Dr. Stephanie Earnshaw, PhD, Senior Vice President, Health Economics at RTI Health Solutions (RTI-HS) on being named a North …
Resources Learn from our experts. Via the tabs to the left, browse our case studies, videos, Knowledgebase infographics, and webinars. …
… of disease frequency Risk factors and comorbidities Clinical practice patterns Utilization and persistence Drug … Example Brief disease backgrounder for use in planning clinical development programs. Incidence of adverse events among a patient population or those taking a certain …
… OPPORTUNITY Our client had multiple phase 1, 2, and 3 clinical trials in hepatocellular carcinoma, renal cell … in reporting requirements across the trials for both clinical study reports and HTA submissions. OUR APPROACH Our …
… to slow kidney function decline in various short-term clinical studies. They wanted to assess their treatment … in kidney function over a longer period, using existing clinical trial data. THE CHALLENGE Our client had data from approximately 10 clinical studies, including single-arm phase 2 studies, …